Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00160-6/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=280173067&_hsenc=p2ANqtz--BUSrfI-dRCuFm7vdRx51cxloJv-mR-wEwGsssEq5ipgRPq4UYET4Rpmeu3xNYSSjAdq6MEYB6yNdkWX8W5mDDl_GT_Q&utm_content=280145645&utm_source=hs_email